Carole Huntsman is CCO at MADRIGAL PHARMACEUTICALS, INC. (MDGL). They have made 3 open-market trades across 1 company since 2024, most recently 2026-03-06.
CIK 0002001571
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 3 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| MDGL | 13,111 | $5.3M |
Shares reported on the most recent Form 4, priced at the 2026-03-06 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| MDGL | SELL | 2026-03-06 | 2026-03-06 | $431.94 | $181K | +3.0% | +24.3% | +14.8% |
| MDGL | SELL · 10b5-1 | 2026-01-26 | 2026-01-26 | $493.78 | $449K | -6.4% | -12.1% | +5.1% |
| MDGL | SELL · 10b5-1 | 2025-11-21 | 2025-11-21 | $552.20 | $1.8M | +7.0% | +10.0% | -20.3% |
| MDGL | SELL · 10b5-1 | 2025-03-03 | 2025-03-05 | $325.64 | $727K | +0.4% | -7.8% | -16.6% |
| MDGL | SELL | 2025-01-24 | 2025-01-27 | $335.24 | $233K | +4.1% | +12.1% | +4.4% |
| MDGL | SELL | 2024-11-21 | 2024-11-22 | $316.92 | $436K | -9.9% | -10.5% | +1.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.